JX Zheng is an associate in our global M&A and Corporate practice based in London.
He has experience advising both domestic and international clients on a broad range of public and private transactions, including mergers and acquisitions, joint ventures, private equity, private funds, equity capital markets and general corporate advisory.
Prior to joining White & Case, JX worked for a leading international law firm, during which time he spent six months on secondment each to the firm's Singapore office and to the legal team of a global investment manager headquartered in Sydney, Australia.
Representation of AMP Capital Funds Management Limited on its responses to proposals to change the responsible entity and investment manager of AMP Capital Community Infrastructure Fund*
Representation of a global private equity firm on its acquisition of an Australian medical and healthcare transport and logistics business*
Representation of a confidential Australian client on the sale of its interest in one of Australia's leading advanced bus equipment manufacturers*
Representation of an Australian superannuation fund on its investment in a co-mingled infrastructure fund*
Representation of the book running lead managers, Kotak Mahindra Capital, Citigroup Global Markets India, Haitong Securities India and Nomura India on the US$872 million IPO of Gland Pharma Limited, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co. Ltd., on India's Bombay Stock Exchange and National Stock Exchange*